Malignant cells hinder the proliferation of cytotoxic T lymphocytes (CTLs) within the tumor by generating immunosuppressive cytokines like interleukin (IL)-10, vascular endothelial growth factor (VEGF), and transforming growth factor beta (TGF-β). This evidence concerns the gene TGFB1 and neoplasm.